Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.240
-0.010 (-0.80%)
At close: Jun 26, 2026, 4:00 PM EDT
1.250
+0.010 (0.81%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Milestone Pharmaceuticals Revenue
Milestone Pharmaceuticals had revenue of $238.00K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $1.78M. In the year 2025, Milestone Pharmaceuticals had annual revenue of $1.55M.
Revenue (ttm)
$1.78M
Revenue Growth
n/a
P/S Ratio
94.56
Revenue / Employee
$46,947
Employees
38
Market Cap
168.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.55M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.00M | -4.00M | -80.00% |
| Dec 31, 2022 | 5.00M | -10.00M | -66.67% |
| Dec 31, 2021 | 15.00M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LENZ Therapeutics | 20.99M |
| ProQR Therapeutics | 15.73M |
| Pyxis Oncology | 13.86M |
| Caribou Biosciences | 11.20M |
| Innate Pharma | 10.57M |
| NRx Pharmaceuticals | 2.29M |
| Kazia Therapeutics | 1.27M |
| YD Bio | 510.36K |
MIST News
- 27 days ago - Milestone Pharmaceuticals Slides: Corporate presentation - Filings
- 5 weeks ago - Milestone Pharmaceuticals Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 6 weeks ago - Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 6 weeks ago - Milestone Pharmaceuticals files $300M mixed securities shelf - TheFly
- 6 weeks ago - Milestone Pharmaceuticals reports Q1 EPS (20c), consensus 19c - TheFly
- 6 weeks ago - Milestone Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Milestone Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Milestone Pharmaceuticals Earnings release: Q1 2026 - Filings